Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone

Neuropharmacology

Volumn 37, Issue 8, 1998, Pages 989-995

  Torstenson, Richard ^a,b   Hartvig, Per ^a,b   Långström, Bengt ^a,b   Bastami, Salumeh ^a   Antoni, Gunnar ^a   Tedroff, Joakim ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apomorphine; l 11C DOPA; Monkey; PET; Tone dependent effect

Indexed keywords

APOMORPHINE; CARBON 11; DOPA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; APOMORPHINE; DOPAMINE; DOPAMINE AGONISTS; FEMALE; INFUSIONS, INTRAVENOUS; LINEAR MODELS; MACACA MULATTA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031665049     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00085-9     Document Type: Article

References (48)

1. Ahlenius, S., Salmi, P., 1994. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmacol. 260, 177-181.
2. Altar, C.A., Berner, B., Beall, P., Carlsen, S.F., Boyar, W.C., 1988. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists. Mol. Pharmacol. 33, 690-695.
3. Andersson, J., 1995. A rapid and accurate method to realign PET scans utilizing image edge information. J. Nucl. Med. 36, 657-669.
4. 11C-labeled L-tyrosine and L-DOPA. Acta Chem. Scand. 44, 183-188.
5. Bunney, B.S., Agahajanian, G.K., 1975. Evidence for drug actions on both pre- and postsynaptic receptors in the CNS. In: Usdin, E., Bunney, W.E. (Eds.), Pre- and Postsynaptic Receptors. Marcel Dekker, New York, p. 89.
6. Bunney, B.S., Agahajanian, G.K., Roth, R.H., 1973. Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nature 245, 123-125.
7. Carlsson, A., 1975. Receptor-mediated control of dopamine metabolism. In: Usdin, E., Bunney, W.E. (Eds.), Pre- and Post-synaptic Receptors. Marcel Dekker, New York, pp. 49-65.
8. Carson, R.E., Huang, S.C., Green, M.V., 1986. Weighted integration method for local cerebral blood flow measurements with positron emission tomography. J. Cereb. Blood Flow Metab. 6, 245-258.
9. Chiodo, L.A., 1992. Dopamine autoreceptor signal transduction in the DA cell body: a 'current view'. Neurochem. Int. 20, 81S-84S.
10. Christiansen, J., Squires, R.F., 1974. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J. Pharm. Pharmacol. 26, 367-369.
11. Davis, K.L., Kahn, R.S., Ko, G., Davidson, M., 1991. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148, 1474-1486.
12. Di Chiara, G., Gessa, G.L., 1978. Pharmacology and neurochemistry of apomorphine. Adv. Pharmacol. Chemother. 15, 87-160.
13. Di Chiara, G., Porceddu, M.L., Vargiu, L., Argiolas, A., Gessa, G.L., 1976. Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264, 564-567.
14. Gancher, S.T., Woodward, W.R., Gliessman, P., Boucher, B., Nutt, J.G., 1990. The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in Parkinsonism. Ann. Neurol. 27, 660-665.
15. Hadjiconstantinou, M., Wemlinger, T.A., Sylvia, C.P., Hubble, J.P., Neff, N.H., 1993. Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J. Neurochem. 60, 2175-2181.
16. 11C]-L-DOPA in humans studied by positron emission tomography. J. Neural Transm. 87, 15-22.
17. Holte, S., Eriksson, L., Dahlbom, M., 1989. A preliminary evaluation of Scanditronix PC 2048-15B scanner. Eur. J. Nucl. Med. 15, 719-721.
18. Jones, S.R., Lee, T.H., Wightman, R.M., Ellinwood, E.H., 1996. Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology 126, 331-338.
19. Koob, G.F., Bloom, F.E., 1988. Cellular and molecular mechanisms of drug dependence. Science 242, 715-723.
20. Kops, R.E., Herzog, H., Schmid, A., Holte, S., Feinendegen, L., 1990. Performance characteristics of an eight ring whole body PET scanner. J. Comput. Assisted Tomogr. 14, 437-445.
21. Långström, B., Dannals, R.F., 1995. Carbon-11 compounds. In: Wagner, H.N., Szabo, Z., Buchanan, J.W. (Eds.), Principles of Nuclear Medicine. W.B. Saunders, Philadelphia, pp. 166-178.
22. Långström, B., Hartvig, P., 1992. Positron emitting tracers in studies of neurotransmission and receptor binding. In: Nunn, A.D. (Ed.), Radiopharmaceuticals. Marcel Dekker, New York, pp. 221-266.
23. 11C]DOPA and its metabolites for the validation of positron emission tomography studies. J. Pharm. Biomed. Anal. 13, 361-367.
24. Menza, M.A., Golbe, L.I., Cody, R.A., Forman, N.B., 1993. Dopamine related personality traits in Parkinson's disease. Neurology 43, 505-508.
25. 11C]dopa. Brain Res. 578, 122-128.
26. Nowak, J.Z., Arbilla, S., Galzin, A.M., Langer, S.Z., 1983. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. J. Pharmacol. Exp. Ther. 226, 558-564.
27. Ostertag, H., Kübler, W.K., Doll, J., Lorenz, W.J., 1989. Measured attenuation correction methods. Eur. J. Nucl. Med. 15, 722-726.
28. Ozaki, N., Nakahara, D., Miura, H., Kasahara, Y., Nagatsu, T., 1989. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method. J. Neurochem. 53, 1861-1864.
29. Przedborski, S., Levivier, M., Raftopoulos, C., Naini, A.B., Hildebrand, J., 1995. Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans. Mov. Disord. 10, 28-36.
30. Ritz, M.C., Lamb, R.J., Goldeberg, S.R., Kuhar, M.J., 1987. Cocain receptors on dopamine transporters are related to the self administration of cocaine. Science 237, 1219-1223.
31. Roth, R.H., 1984. CNS dopamine autoreceptors: distribution, pharmacology, and function. Ann. New York Acad. Sci. 430, 27-53.
32. Saller, C.F., Salama, A.I., 1985. Alterations in dopamine metabolism after chronic administration of haloperidol. Possible role of increased autoreceptor sensitivity. Neuropharmacology 24, 123-129.
33. Strömberg, U., 1970. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine. Psychopharmacologia 18, 58-67.
34. Strömbom, U., 1976. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 167-176.
35. 11C]-3,4-dihydroxyphenyl-alanine (DOPA) in the primate by positron emission tomography. Acta Neurol. Scand. 85, 166-173.
36. Tedroff, J., Aquilonius, S.M., Hartvig, P., Långström, B., 1994. Functional positron emission tomographic studies of striatal dopaminergic activity. Changes induced by drugs and nigrostriatal degeneration. Adv. Neurol. 69, 443-448.
37. Tedroff, J., Torstenson, R., Hartvig, P., Lindner, K.J., Watanabe, Y., Bjurling, P., Westerberg, G., Långström, B., 1997. L-DOPA modulates striatal dopaminergic function in vivo: Evidence from PET investigations in nonhuman primates. Synapse 25, 56-61.
38. Tedroff, J., Torstenson, R., Hartvig, P., Sonesson, C., Waters, N., Carlsson, A., Neu, H., Fasth, K.-J., Långström, B., 1998. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU 6162 on PET measurements in subhuman primates. Evidence for tone-dependent normalization of striatal dopaminergic activity. Synapse 28, 280-287.
39. Tissari, A.H., Lillgals, M.S., 1993. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration. J. Neurochem. 61, 231-238.
40. Torstenson, R., Hartvig, P., Långström, B., Westerberg, G., Tedroff, J., 1997. Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease. Ann. Neurol. 41, 334-340.
41. 11C]DOPA disposition in the monkey brain. Brain Res. 713, 92-98.
42. Ungerstedt, U., Herrera-Marschitz, M., Brugue, M.C., 1981, Are apomorphine, bromocriptine, and the methylxanthines agonists at the same dopamine receptor? In: Corsini, G.U., Gessa, G.L. (Eds.), Apomorphine and Other Dopaminomimetics, vol. 1, Basic Pharmacology. Raven Press, New York, pp. 85-93.
43. Vogelsang, G.D., Piercey, M.F., 1985. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol. Eur. J. Pharmacol. 110, 267-269.
44. Walters, J.R., Roth, R.H., 1976. Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endogenous dopamine after cessation of impulse flow. Biochem. Pharmacol. 25, 649-654.
45. Wise, R.A., 1988. Catecholamine theories of reward: a critical review. Brain Res. 152, 215-217.
46. Wolf, M.E., Roth, R.H., 1987. Dopamine autoreceptors. In: Creese, I., Fraser, C.M. (Eds.), Receptor Biochemistry Methodology: Dopamine Receptors. Alan R. Liss, New York, pp. 45-96.
47. 3H-DA release by D2 autoreceptors. Pharmacol. Biochem. Behav. 36, 457-461.
48. Zhu, M.Y., Juorio, A.V., Paterson, A., Boulton, A.A., 1993. Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur. J. Pharmacol. 238, 157-164.